C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2006
12/12/2006	CA2281695C Process for the preparation of substituted thiazolidinedione
12/12/2006	CA2140106C Method of treating hyperproliferative vascular disease
12/12/2006	CA2121871C A prophylactic or therapeutic drug for renal diseases
12/07/2006	WO2006129649A1 Processes for production of optically active ppar-activating compounds and intermediates for production thereof
12/07/2006	WO2006129587A1 Pharmaceutical composition comprising pyrazolone derivative
12/07/2006	WO2006129583A1 Pyrazolone derivative
12/07/2006	WO2006129432A1 Carboxamide compound and use thereof
12/07/2006	WO2006129199A1 Novel heterocyclic compounds as positive allosteric modulators of metabotropic glutamate receptors
12/07/2006	WO2006129100A1 Novel compounds
12/07/2006	WO2006129064A1 Quinazolines and their use as aurora kinase inhibitors
12/07/2006	WO2006128803A1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
12/07/2006	WO2006128562A1 Use of chromone derivatives
12/07/2006	WO2006057977A3 Cycloalkyl piperidine tachykinin receptor antagonists
12/07/2006	WO2006044362A3 N-sulfonylpiperidine cannabinoid receptor 1 antagonists
12/07/2006	US20060276643 Amine-substituted diphenyldiphosphines
12/07/2006	US20060276520 Rhodanine derivatives and pharmaceutical compositions containing them
12/07/2006	US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/07/2006	US20060276514 Tyrosine kinase inhibitors
12/07/2006	US20060276511 Inhibitors of HCV replication
12/07/2006	US20060276509 Tripeptidyl peptidase inhibitors
12/07/2006	US20060276506 Compounds for the treatment of inflammatory disorders
12/07/2006	US20060276494 Novel sulfonamides as L-CPT1 inhibitors
12/07/2006	US20060276487 New compounds useful for DPP-IV enzyme inhibition
12/07/2006	US20060276479 Heterocyclic substituted piperazines with CXCR3 antagonist activity
12/07/2006	US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
12/07/2006	US20060276465 1,2-di(cyclic) substituted benzene compounds
12/07/2006	US20060276462 Method of treating cognitive decline due to sleep deprivation and stress
12/07/2006	US20060276461 Prostaglandin analogs
12/07/2006	US20060276448 Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity
12/07/2006	US20060276434 3-Carbonylaminothiophenes and their use as fungicides
12/07/2006	US20060276433 Hydrazone derivative
12/07/2006	DE102005026194A1 Substituierte N-Benzo[d]isoxazol-3-yl-amin-Derivate und deren Verwendung zur Herstellung von Arzneimitteln N-substituted benzo [d] isoxazol-3-yl-amine derivatives and their use for the preparation of medicaments
12/07/2006	DE102005025801A1 Verwendung von Chromonderivaten Use of Chromonderivaten
12/07/2006	CA2650999A1 Substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases
12/07/2006	CA2609513A1 Novel heterocyclic compounds as positive allosteric modulators of metabotropic glutamate receptors
12/07/2006	CA2609355A1 Organic compounds
12/07/2006	CA2608819A1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
12/06/2006	EP1727815A1 Ether derivatives, their manufacture and use as pharmaceutical agents
12/06/2006	EP1727814A1 Nucleoside analogues with antiviral activity
12/06/2006	EP1727809A1 Substituted morpholine and thiomorpholine derivatives
12/06/2006	EP1727806A1 2,4-diaminopyrimidines and their use for inducing cardiomyogenesis
12/06/2006	EP1727794A1 Novel benzyl(idene)-lactam derivatives
12/06/2006	EP1727542A2 Compouns, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor
12/06/2006	EP1572668A4 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
12/06/2006	EP1438304B1 Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists
12/06/2006	EP1091738B1 BICYCLIC sPLA 2 INHIBITORS
12/06/2006	CN1874768A N3 alkylated benzimidazole derivatives as MEK inhibitors
12/06/2006	CN1288152C 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same
12/06/2006	CN1288151C Metal complex type luminous material containing electron injection group and its preparation method
12/06/2006	CN1288150C Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases
12/05/2006	US7145013 N-[4-[[4-(5-chloro-2-hydroxyphenyl)-1,2-dihydro-2-oxo-6-(trifluoromethyl)-3-quinolinyl]thio]phenyl]ethanesulfonamide for example; potassium channel modulators for treating erectile dysfunction and irritable bowel syndrome
12/05/2006	US7145006 PNA monomer and precursor
12/05/2006	US7144911 Anti-inflammatory medicaments
12/05/2006	US7144906 Heterocyclic compounds
12/05/2006	US7144901 Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
12/05/2006	US7144896 heterocyclic imines such as 3-[6-(1-Methanesulfonyl-1-methyl-ethyl)-quinolin-8-yl]-N-[6-(4-methylsulfanyl-phenyl)-pyridin-3-yl]-benzamide, used as phosphodiesterases (pde4) inhibitors; side effect reduction
12/05/2006	US7144888 Vanilloid receptor ligands and their use in treatments
12/05/2006	US7144885 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
12/05/2006	US7144882 Central nervous system disorders; psychological disorders; inflammatory bowel disorders
12/05/2006	US7144880 Compositions relating to novel compounds and targets thereof
12/05/2006	CA2360313C Glucocorticoid receptor modulators
12/05/2006	CA2189652C Novel hydroximic acid derivatives, pharmaceutical compositions containing them and process for preparing same
11/2006
11/30/2006	WO2006127396A1 Par2-modulating compounds and their use
11/30/2006	WO2006127364A1 Apoptosis promoters
11/30/2006	WO2006126939A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
11/30/2006	WO2006126695A1 Pyrazole compound and therapeutic agent for diabetes comprising the same
11/30/2006	WO2006126514A1 Arylacetate derivative having isoxazole skeleton
11/30/2006	WO2006126171A2 New antibiotic derivatives
11/30/2006	WO2006126074A2 Heterocyclic derivatives
11/30/2006	WO2006125972A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
11/30/2006	WO2006125637A1 O-(phenyl/heterocyclyl)methyl oxime ether compounds for combating animal pests
11/30/2006	WO2006125621A1 Substituted piperidines as renin inhibitors
11/30/2006	WO2006125370A1 Aromatic ether compounds,preparation and usage thereof
11/30/2006	WO2006103045B1 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
11/30/2006	WO2006100181A3 New salt and polymorphs of a dpp-iv inhibitor
11/30/2006	WO2006092291A3 Method for producing alkyl anilides
11/30/2006	WO2005089753A3 Daao inhibiting bξnzisoxazoles and their use for the treatment of mental disorders
11/30/2006	WO2005080384A9 Benzimidazole derivative and use as aii receptor antagonist
11/30/2006	US20060270850 Processes for preparation of pyrimidine derivatives and intermediates
11/30/2006	US20060270721 EP4 receptor agonist, compositions and methods thereof
11/30/2006	US20060270706 Cyclic amine derivative having heteroaryl ring
11/30/2006	US20060270687 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states
11/30/2006	US20060270680 Sulfonamide compounds and methods of making and using the same
11/30/2006	US20060270674 Pharmaceutical composition promoting defecation
11/30/2006	US20060270673 Inhibitors of akt activity
11/30/2006	US20060270672 4-amino-6-cycloalkyloxy-7-substituted quinazolines; inhibition of signal transduction mediated by tyrosine kinases; antitumor agents, respiratory system and gastrointestinal disorders
11/30/2006	US20060270670 Methods of synthesizing 6-alkylaminoquinoline derivatives
11/30/2006	US20060270669 Method of preparing 3-cyano-quinolines and intermediates made thereby
11/30/2006	US20060270668 Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof
11/30/2006	US20060270666 Quinoxaline derivatives as neutrophil elastase inhibitors and their use
11/30/2006	US20060270660 Processes for preparing substituted pyrimidines
11/30/2006	US20060270657 N-substituted heterocyclic sulfonamides
11/30/2006	US20060270652 Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists
11/30/2006	US20060270651 Antibacterial agents
11/30/2006	US20060270637 Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents
11/30/2006	US20060270632 4-(2-Furoyl) aminopiperidine compound useful as therapeutic agent for itching
11/30/2006	US20060269609 preparing 6-methyl-2-[4-(4-morpholino)anilino]nicotinic acid by reacting 2-chloro-6-methylnicotinic acid with 4-(4-morforino)aniline; effective for inhibiting the replication of hepatitis C virus
11/30/2006	CA2609747A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphthalene derivatives modulating the 5ht6 receptor
11/30/2006	CA2609394A1 Pyrazole compound and therapeutic agent for diabetes comprising the same
11/30/2006	CA2609235A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes

1 ... 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 ... 647